# pathology/ — Status

**12 of 12 guides AUTHORED + INTEGRATED + BACKFILLED + REVIEWED · Module COMPLETE · Pulse 05 DONE · Final reviewer PASS · Silver for all 12 · No registry insertion · No unresolved BLOCK/WARN**

> `pathology/` is the **mechanism-to-diagnosis bridge** of the Life Sciences vertical: it
> owns *why a lesion looks and behaves the way it does*, *how a laboratory result is
> generated*, and *how a morphologic pattern becomes a signed diagnosis*. All **twelve
> guides are now authored at full peer depth**: the two highest-risk boundary guides were
> prototyped and gate-reviewed first — `08-LABORATORY-MEDICINE` (which resolves the
> three-way lab-interpretation split without drifting into the `medicine/10` catalog or
> `clinical-medicine/03` belief math) and `10-DIAGNOSIS-PATTERN-RECOGNITION-AND-REPORTING`
> (which teaches a *reusable diagnostic method*, not a disease catalog) — followed by the
> two scaling-gate guides `09`/`11`, and finally the `00-OVERVIEW` map and the seven
> mechanism guides `01`–`07`, each bound by the four-pillar contract and the hard defers to
> `disease/`.
>
> The module is now **integrated** into `sections/life-sciences.md`, `.mkdocs/mkdocs.yml`,
> and `TRACKER.md`; the **architecture-approved minimal reciprocal sibling pointers** are
> in place (`disease/00-OVERVIEW` → pathology fundamentals `01`–`03`; `disease/04-CANCER` →
> tumor grading/pTNM/IHC depth `05`/`10`; `medicine/10-DIAGNOSTICS-IMAGING` → lab-result
> generation `08`, preserving its `clinical-medicine/03` decision-theory pointer; and the
> `clinical-medicine/03` forward pointer to `pathology/` is accurate); and the
> **source-corpus backfill** (PROOF/CROP/PEBBLE/FLETCH) has been run. The full-module
> adversarial `expert-skeptic` + `reference-editor` panel is clean after repair, and the
> guide-specific R2 Gold-rubric/reader-task evidence is recorded. The honest tier is
> **Silver** because pathology-specific Da Vinci invariants are absent and source custody
> remains partial; no Gold registry rows were added. The final reviewer returned
> **PASS** with no BLOCK/WARN. The module is **COMPLETE** and Pulse 05 is **DONE**. The architecture record
> lives at
> `context/waves/2026-07-11-clinical-and-chemical-foundations/artifacts/PATHOLOGY-ARCHITECTURE.md`
> (findings MAXIM-PATH-01 … MAXIM-PATH-25 + per-guide IDs), and the pulse record at
> `pulses/05+pathology-architecture.md`.

## Scope in one line

`pathology/` is the **mechanism-to-diagnosis bridge** of the Life Sciences vertical
(molecular → cellular → **tissue/lesion** → laboratory → **diagnosis**). It owns the
*causal chain from injury to observable finding to diagnosis*: general/cellular
pathology mechanisms, how laboratory results are generated and bounded, anatomic
technique, and the reasoning that turns a morphologic pattern into a reported
diagnosis. It is **not** a disease catalog, a reference-range/test catalog, a belief-
updating decision theory, or a set of laboratory operating procedures. It is an
**educational reference, never medical advice**.

## Guide Manifest (12 guides: 00 + 11)

| # | File | Uniquely owns (at peer depth) | Status |
|---|------|-------------------------------|--------|
| 00 | `00-OVERVIEW.md` | Discipline map (general vs systemic; anatomic vs clinical pathology); the mechanism→result→diagnosis spine; ownership/boundary table; module **non-advice contract**; reading order; software-mental-model bridges | ✅ **authored / reviewed** |
| 01 | `01-CELL-INJURY-ADAPTATION-AND-DEATH.md` | Reversible vs irreversible injury; hypoxia/ischemia/oxidative stress; adaptations (hypertrophy, hyperplasia, atrophy, metaplasia); necrosis patterns vs apoptosis; accumulations, calcification, aging | ✅ **authored / reviewed** |
| 02 | `02-INFLAMMATION-AND-TISSUE-REPAIR.md` | Acute vs chronic inflammation as a program; vascular/cellular events; mediators; granulomatous pattern; resolution, regeneration, scarring, fibrosis; wound healing | ✅ **authored / reviewed** |
| 03 | `03-HEMODYNAMIC-DISORDERS-THROMBOSIS-AND-SHOCK.md` | Edema, congestion, hemostasis, Virchow's triad, thrombosis, embolism, infarction, shock classes as a mechanistic cascade | ✅ **authored / reviewed** |
| 04 | `04-IMMUNOPATHOLOGY-AND-TISSUE-INJURY.md` | Hypersensitivity I–IV as *tissue-injury mechanisms*, autoimmunity, transplant rejection, immunodeficiency-as-lesion — deferring immune-cell biology to `immunology/` | ✅ **authored / reviewed** |
| 05 | `05-NEOPLASIA-CARCINOGENESIS-AND-TUMOR-BIOLOGY.md` | Hallmarks of cancer; benign vs malignant; differentiation/anaplasia; invasion/metastasis mechanism; carcinogenesis; tumor nomenclature *principles* (not a tumor catalog) | ✅ **authored / reviewed** |
| 06 | `06-GENETIC-DEVELOPMENTAL-AND-METABOLIC-PATHOLOGY.md` | Inherited-disease *pathology* principles; developmental/malformation mechanisms; inborn errors and storage as tissue lesions — deferring gene mechanism to `genomics/` | ✅ **authored / reviewed** |
| 07 | `07-ENVIRONMENTAL-NUTRITIONAL-AND-TOXIC-INJURY.md` | Physical/chemical/toxic injury mechanisms; nutritional-deficiency and overload lesions; environmental exposure pathology | ✅ **authored / reviewed** |
| 08 | `08-LABORATORY-MEDICINE.md` | **How a laboratory result is generated and bounded** — total testing process; analytical vs clinical Sn/Sp; imprecision/bias/linearity/measurement uncertainty; interference; method comparison/harmonization; cell counting + smear-morphology interface; result validation/flags. Owns the *result*; defers the catalog to `medicine/10` and the belief-update to `clinical-medicine/03` | ✅ **authored / reviewed** (prototype and full-module findings repaired) |
| 09 | `09-ANATOMIC-PATHOLOGY-TECHNIQUE.md` | How a slide/diagnosis substrate is made: gross-to-glass, fixation, processing, sectioning, staining principles, frozen section, cytology prep, IHC/molecular *substrate* — the technique behind the pattern (principles, not SOPs) | ✅ **authored / reviewed** — Stage-2 whole-procedure PASS; full-module technique findings repaired |
| 10 | `10-DIAGNOSIS-PATTERN-RECOGNITION-AND-REPORTING.md` | **Morphology-to-diagnosis reasoning and the report as an interface** — pattern recognition, differential pattern classes, ancillary-test integration, diagnostic-certainty language, grading/staging/margin *principles*, synoptic vs narrative reports, critical-result communication, amended reports. Multi-organ examples teach a *reusable method*, not a catalog | ✅ **authored / reviewed** (prototype and full-module findings repaired) |
| 11 | `11-QUALITY-ERROR-AND-THE-DIAGNOSTIC-LABORATORY-AS-SYSTEM.md` | The laboratory/diagnostic service as a system: QC/QA, error taxonomy across the total testing process, EQA/proficiency, accreditation frameworks *as concepts*, turnaround/flow, diagnostic safety and the brain-to-brain loop | ✅ **authored / reviewed** — Stage-2 whole-seam PASS after repair and clean review |

Per-guide architecture IDs (MAXIM-PATH-G00 … G11) and the manifest are ratified in the
Pulse-05 architecture record. Guides `08` and `10` were authored at full peer depth as
gate-candidate prototypes; guides `09` (anatomic technique) and `11` (laboratory-as-quality-
system) were authored at full peer depth under their scaling mini-contracts, with `09`'s
Stage-2 whole-procedure review a PASS and `11`'s Stage-2 whole-seam review a PASS after
repair. **The `00-OVERVIEW` map and the
seven mechanism guides `01`–`07` are now authored at full peer depth**, each carrying the
four-pillar banner, the ownership/defer header, a landscape diagram, the layered
molecular→cellular→tissue formalism, worked fictional cases, decision-useful tables, systems
bridges, 3–5 solved reader tasks, a Decision Cheat Sheet, Common Confusion Points, and
resource/geographic/bias caveats, and hard-deferring disease entities to `disease/`,
immune-cell biology to `immunology/`, gene mechanism to `genomics/`, and organism biology to
`microbiology/`/`virology/`. All twelve guides pass **focused Cargo PROOF** (`0 errors, 0
warnings`) and carry **0** second-person (`you/your`) voice. **All twelve guides are
authored, integrated, backfilled, and reviewed**. The full-module adversarial panel and R2
Gold-rubric/reader-task review are complete with no unresolved BLOCK/WARN. The module is **COMPLETE** and Pulse 05 is **DONE** after final PASS (see the architecture
record, MAXIM-PATH-24, and the Pulse-05 review record).

## Boundary Contracts (non-duplication)

This module names mechanisms/catalogs by reference and never re-derives them.

| Defers to | For |
|---|---|
| `medicine/10-DIAGNOSTICS-IMAGING` | The **test catalog**, reference intervals/ranges, panel membership, analyte time-courses, and imaging **physics**. `pathology/08` owns *how the result is produced and bounded*; `medicine/10` owns *which tests exist and their bands*. |
| `clinical-medicine/03-DIAGNOSTIC-TEST-INTERPRETATION` | **Bayesian belief updating** — pretest/posttest probability, likelihood ratios, test/treatment thresholds, and the decision to act. `pathology/08` stops at the released result and its uncertainty; it does **not** update a clinician's belief. |
| `clinical-medicine/02-DIFFERENTIAL-DIAGNOSIS` | The *clinical* differential and its cognitive-bias framing. `pathology/10` owns the *morphologic* differential-by-pattern and the report; it borrows the dual-process parallel by reference. |
| `disease/` | Disease entities, catalogs, and natural history. `pathology/` uses lesions only as *illustrations of a mechanism or method*; it does not enumerate diseases. |
| `immunology/` | Immune-cell biology and signaling. `pathology/04` owns hypersensitivity/autoimmunity **as tissue-injury mechanisms**. |
| `microbiology/`, `virology/` | Organism biology and taxonomy. `pathology/08` owns *how a microbiology/molecular result is generated*, not the organisms themselves. |
| `genomics/`, `biochemistry/`, `human-biology/` | Gene/pathway/normal-structure mechanism. `pathology/` owns the *lesion*, not normal function. |
| `chemistry/04-ANALYTICAL-QUANTITATIVE` | The general analytical formalism (calibration, LOD/LOQ, method validation). `pathology/08` applies it to the *clinical laboratory* and its biological matrices. |
| `public-health/`, `statistics-applied/` | Population screening **programs** and study-design methods. `pathology/` is the individual specimen and the bench. |
| `law/`, `criminology/` | Statute, precedent, and forensic/legal adjudication. Forensic/autopsy **legal** determination is out of scope; no forensic or legal advice is given. |

**Three-way lab-interpretation split (ratified with this module):**
`pathology/08` = *how the result is generated and how far to trust it* →
`medicine/10` = *the catalog, panels, and reference bands* →
`clinical-medicine/03` = *how a clinician updates belief and decides to act*.

## Non-Advice / Non-Procedure Contract (hard review gate)

A four-pillar safety contract governs every guide (see the architecture record):

1. **No self-diagnosis / no personal-result interpretation.** Content explains *how the
   laboratory and the pathologist produce and reason about findings in general*, never
   what any reader's own result or lesion means.
2. **No specimen-collection or laboratory-operating instructions.** No phlebotomy,
   collection, assay setup, staining, or bench SOPs; technique is described at the level
   of *principle and constraint*, not as a runnable procedure.
3. **No forensic/legal advice.** Autopsy/forensic content, where mentioned, is
   conceptual; no cause-of-death, manner-of-death, or legal determinations.
4. **Third-person descriptive voice, illustrative and dated numbers.** No second-person
   imperatives; every numeric threshold/metric is labeled illustrative and attributed
   where it names a real standard. `expert-skeptic` review carries an explicit
   advice-creep / procedure-creep checklist; any imperative-mood self-diagnosis,
   result-interpretation, or bench-procedure instruction is a **BLOCK**.

## Placement (WIRED)

Home: **Life Sciences** section, as the mechanism-to-diagnosis bridge between
`disease/`/`human-biology/` and `clinical-medicine/`. Integration is **complete**:

- `sections/life-sciences.md` — a Directories-table row for `pathology/` (entry point +
  bridges) and the directory count updated.
- `.mkdocs/mkdocs.yml` — a `Pathology: pathology/00-OVERVIEW.md` nav entry in the Life
  Sciences section.
- `TRACKER.md` — a summary-dashboard row for `pathology/` (12 guides, in-review marker) and
  the clinical-and-chemical-foundations wave line updated.
- **Architecture-approved minimal reciprocal sibling pointers** added: `disease/00-OVERVIEW`
  (compact pathology fundamentals → `pathology/01`–`03`), `disease/04-CANCER` (tumor
  grading/pTNM/IHC depth → `pathology/05` and `pathology/10`), and
  `medicine/10-DIAGNOSTICS-IMAGING` (lab-result generation/technical reliability →
  `pathology/08`, preserving its `clinical-medicine/03` decision-theory pointer). The
  existing `clinical-medicine/03` forward pointer to `pathology/` was verified and made
  accurate (the placeholder "(planned)" removed). No other sibling content was rewritten.
- **Source-corpus backfill** (PROOF/CROP/PEBBLE/FLETCH) has been run for `pathology/` and for
  every sibling module whose canonical guide changed (`disease/`, `medicine/`,
  `clinical-medicine/`); guide frontmatter is promoted to `status: source-custody` /
  `source_custody: partial` with recorded backsource IDs.

Integration did **not by itself** grant sign-off: the full-module adversarial panel
(`panels/pathology-full-r1/`) was **run (2026-07-12) and its findings repaired**, and the R2
rubric confirmed Silver for all twelve with no registry insertion. The final reviewer then
returned **PASS** with no BLOCK/WARN, completing the module.

## Pulse 05 review status

Architecture ratified and recorded; all twelve guides authored at full depth and
focused-PROOF-clean; the module integrated, reciprocally wired, and source-backfilled. The
prototype review (adversarial `expert-skeptic` + `reference-editor` over `08`/`10`) has been
run as **round R1**, recorded under
`context/waves/2026-07-11-clinical-and-chemical-foundations/panels/pathology-prototype-r1/`.
R1's findings are **repaired** in `08`/`10` and the architecture record — the metrology
honesty split (calculated vs allowable total error, the relative-change RCV, the LoB
percentile), the bounded/attributed preanalytic-error range, the analytical-validity-vs-
diagnostic-evidence split, the independent certainty dimensions on locally governed
lexicons, the actual versioned report payload, the multidimensional parse matrix, the
report-scope corrections (pathologic TNM elements vs overall stage; protocol-governed vs
heterogeneous synoptic completeness; no universal "cannot sign"), resource-constrained case
branches, the recast to third-person institutional model states, the qualified framework
citations, and the `09`/`11` scaling mini-contracts.

A strict re-review — **round R2**, recorded under
`context/waves/2026-07-11-clinical-and-chemical-foundations/panels/pathology-prototype-r2/`
— closed the remaining finer-grained findings: `08`'s total error split into matched-unit
**absolute** (`TEcalc_abs = |bias_abs| + z·SD_abs` vs `TEa_abs`) and **percent**
(`TEcalc_% = |bias_%| + z·CV_%` vs `TEa_%`) forms with a stated one-sided-z convention and a
percentage sigma `(TEa_% − |bias_%|)/CV_%`; **RCV reserved for serial within-person change**
on the same or a comparable method, with the cross-hospital/method RCV recommendation
removed in favor of method bias, uncertainty, commutability, calibration traceability, and
method-comparison evidence; `10`'s ancillary section separating **spectrum-dependent
Sn/Sp/LR from prevalence-dependent PPV/NPV/posterior** (no claim that prevalence changes
Sn/Sp/LR; posterior math deferred to `clinical-medicine/03`); **margin** wording corrected
to *tumor presence/absence/distance at the examined inked specimen margins*, explicitly
**not proof of complete excision**; the thyroid-FNA example distinguishing **unavailable
tissue-level architecture/invasion from diagnostically meaningful cytologic group
arrangements** (e.g., microfollicular patterns); the `09`/`11` scaling contracts expanded to
a **two-stage gate** (representative high-risk draft sections before authoring + a
completed-guide whole-procedure/whole-seam review before sign-off); and the **prototype
frontmatter made truthful** (`status: prototype`, `source_custody: needs-source`,
`backsource_ids: []`), no longer claiming proof-backfill/git-history artifacts that do not
yet exist and remaining forward-compatible with the deferred backfill (MAXIM-PATH-25).

**Historical prototype-round state — superseded by final PASS on 2026-07-12.** Under the
boundary-review scope, R1/R2 gated
authoring rather than granting module sign-off; authoring of the remaining guides,
integration, reciprocal sibling cross-references, and the source-corpus backfill have **now
been performed** in the authoring/integration round, and the **full-module adversarial panel
has since been run (2026-07-12), recorded under `panels/pathology-full-r1/`
(`expert-skeptic` + `reference-editor` + consolidated); its findings are repaired** in the
guides and the backfill generator; the R2 rubric then confirmed the residual set clean and
assigned Silver to all twelve guides without registry insertion. The final reviewer returned
**PASS** with no BLOCK/WARN, so the module is **COMPLETE** and Pulse 05 is **DONE**. (The
prototype frontmatter, truthfully `needs-source` at R2, has
since been promoted to `source_custody: partial` by the completed source-corpus backfill in
this round, consistent with MAXIM-PATH-25.)

### Scaling-gate authoring — guides 09 and 11 (guide 09 Stage-2 PASS; guide 11 Stage-2 PASS)

Under the Pulse-05 scaling mini-contracts (MAXIM-PATH-24), the two scaling-risk guides `09`
and `11` have now been **authored and reviewed at full MAXIM peer depth**. Their guide-level
gates are complete, and Pulse-05 final sign-off is **PASS**. The scaling-gate record lives at
`context/waves/2026-07-11-clinical-and-chemical-foundations/pulses/05+pathology-architecture.md`
(Scaling-Gate section) with completed two-stage panel records under
`context/waves/2026-07-11-clinical-and-chemical-foundations/panels/pathology-09-scaling/` and
`.../panels/pathology-11-scaling/`.

- `09-ANATOMIC-PATHOLOGY-TECHNIQUE.md` — gross-to-glass substrate technique written strictly
  as *purpose → failure mode → downstream consequence* with **no runnable procedures, no
  reagents/times/temperatures/dilutions/cutting sequences, and no block counts**. The
  Stage-1 high-risk surfaces (grossing/orientation sampling logic; staining; frozen section;
  cytology preparation) are covered in-guide within the no-SOP boundary. **Stage 2 — the
  completed-guide whole-procedure `expert-skeptic` review over the entire gross-to-glass
  surface — has been run and PASSES (2026-07-12); the no-runnable-steps (pillar-2) contract
  holds end to end. This clears guide 09's per-guide gate (recorded in
  `panels/pathology-09-scaling/`); guide 11's Stage-2 whole-seam review also passes, so both
  scaling gates are cleared.**
- `11-QUALITY-ERROR-AND-THE-DIAGNOSTIC-LABORATORY-AS-SYSTEM.md` — the diagnostic service as a
  system: cross-process QC/QA/EQA, the phase-indexed error taxonomy, validation/verification
  and document/change-control **governance**, accreditation/competence **as concepts** (dated,
  attributed, non-prescriptive — no accreditation how-to or jurisdiction-specific compliance
  steps), incident/CAPA/amendment loops, turnaround/traceability, the conceptual autopsy/audit
  boundary (forensic cause/manner-of-death **out of scope**, pillar 3), and system resilience.
  The **`08`↔`11` seam** is explicit — `08` owns per-result metrology and only the local QC it
  needs to bound one result; `11` owns the cross-process program and re-derives none of `08`'s
  metrology — and the general clinical system-safety science (Swiss-cheese, just culture, RCA,
  HRO, Donabedian, PDSA) is **deferred to `clinical-medicine/11`**. The Stage-1 high-risk
  surfaces (governance/accreditation; the total-testing-process `08`↔`11` error-taxonomy/QC
  seam) are covered in-guide. **Stage 2 — the completed-guide whole-seam `expert-skeptic`
  review — has been run (2026-07-12) and returned seam/accuracy findings (the `08`↔`11` EQA/PT
  seam, QC chart semantics, CAPA, accreditation, validation/verification, nonconforming-work/
  amendment stratification, audit-instrument/traceability distinctions, and a resource-
  constrained case/task). All findings are repaired in the guide, and the **clean re-review has
  since been run — folded into the full-module `pathology-full-r1` pass — and guide 11 PASSES**
  (recorded in `panels/pathology-11-scaling/`), clearing its scaling gate.**

Both guides pass **focused Cargo PROOF** (`0 errors, 0 warnings`) and carry the four-pillar
banner, the ownership/defer header, landscape + layered formalism, worked fictional cases,
decision tables, systems bridges, reader tasks, a Decision Cheat Sheet, Common Confusion
Points, and resource/bias caveats. Frontmatter has been promoted from the pre-backfill state
to `status: source-custody` / `source_custody: partial` by the completed source-corpus
backfill. Following this authoring/integration round, the module is **AUTHORED (12/12),
INTEGRATED, BACKFILLED, and REVIEWED**: the full-module adversarial panel
(`pathology-full-r1`) and R2 Gold-rubric review are complete with no unresolved BLOCK/WARN.
The final reviewer returned **PASS**; the module is **COMPLETE** and Pulse 05 is **DONE**.
